A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy

Kwang-il Kim; Mi-Seung Shin; Sang-Hyun Ihm; Ho-Joong Youn; Ki-Chul Sung; Shung Chull Chae; Chang-Wook Nam; Hong Seog Seo; Seong-Mi Park; Moo-Yong Rhee; Moo Hyun Kim; Kwang Soo Cha; Yong-Jin Kim; Jae-Joong Kim; Kook Jin Chun; Byung-Su Yoo; Sungha Park; Eun-Seok Shin; Dong-Soo Kim; Doo Il Kim; Kye Hun Kim; Seung-Jae Joo; Jin-Ok Jeong; Jinho Shin; Cheol Ho Kim

doi:10.1016/j.clinthera.2016.07.008

A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.07.008 ◽

2016 ◽

Vol 38 (10) ◽

pp. 2159-2170 ◽

Cited By ~ 4

Author(s):

Kwang-il Kim ◽

Mi-Seung Shin ◽

Sang-Hyun Ihm ◽

Ho-Joong Youn ◽

Ki-Chul Sung ◽

...

Keyword(s):

Essential Hypertension ◽

Combined Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Multicenter Phase ◽

Phase Iii Study

Download Full-text

[PP.12.23] A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE TRIPLE COMBINATION OF AMLODIPINE/LOSARTAN/ROSUVASTATIN IN PATIENTS WITH ESSENTIAL HYPERTENSION

Journal of Hypertension ◽

10.1097/01.hjh.0000523533.01598.7c ◽

2017 ◽

Vol 35 ◽

pp. e193

Author(s):

H. Lee ◽

S. Park

Keyword(s):

Essential Hypertension ◽

Phase Iii ◽

Efficacy And Safety ◽

Triple Combination ◽

Double Blind ◽

Phase Iii Study

Download Full-text

1339P Efficacy and safety of MIL60, a bevacizumab biosimilar, in combination with paclitaxel/carboplatin in patients with advanced or recurrent non-squamous non-small cell lung cancer: A randomized, double-blind, multicenter phase III study

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1940 ◽

2021 ◽

Vol 32 ◽

pp. S1023

Author(s):

J. Wang ◽

R. Wang ◽

X. Dong ◽

Q. Chen ◽

Y. Yu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Multicenter Phase ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Stage Iiib ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Case Medical Research ◽

10.31525/ct1-nct04063163 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Extensive Stage

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718340215.793493941 ◽

2014 ◽

Author(s):

Kamran Ghoreschi ◽

Sebastian Volc

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Faculty Opinions recommendation of Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718874797.793499746 ◽

2014 ◽

Author(s):

Mark Levis

Keyword(s):

At Risk ◽

Uric Acid ◽

Tumor Lysis Syndrome ◽

Phase Iii ◽

Efficacy And Safety ◽

Tumor Lysis ◽

Plasma Uric Acid ◽

Multicenter Phase ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension

Clinical Therapeutics ◽

10.1016/j.clinthera.2021.08.003 ◽

2021 ◽

Author(s):

Hae-Young Lee ◽

Kwang-il Kim ◽

Sang Hyun Ihm ◽

Moo-Yong Rhee ◽

Il Suk Sohn ◽

...

Keyword(s):

Essential Hypertension ◽

Elderly Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Multicenter Phase ◽

Parallel Group ◽

Phase Iiib

Download Full-text

Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2017.08.013 ◽

2017 ◽

Vol 39 (10) ◽

pp. 2049-2060 ◽

Cited By ~ 2

Author(s):

Soon Jun Hong ◽

Han Saem Jeong ◽

Seung Hwan Han ◽

Ki Yuk Chang ◽

Bum Kee Hong ◽

...

Keyword(s):

Phase Iii ◽

Losartan Potassium ◽

Fixed Dose ◽

Double Blind ◽

Multicenter Phase ◽

Phase Iii Study

Download Full-text

Comparison of the Efficacy and Safety Profiles of a Pelubi Sustained Release Tab Versus a Pelubi Tab in Patients with Chronic Back Pain: A Randomized, Double-Blind, Multi-Institution Phase III Study

Journal of Korean Society of Spine Surgery ◽

10.4184/jkss.2016.23.2.92 ◽

2016 ◽

Vol 23 (2) ◽

pp. 84

Author(s):

Ki Taek Kim ◽

Tae Kyun Kim ◽

Ji Woong Choi ◽

Jae Sung Ahn ◽

Young Do Koh ◽

...

Keyword(s):

Back Pain ◽

Sustained Release ◽

Chronic Back Pain ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.01.897 ◽

2014 ◽

Vol 71 (3) ◽

pp. 484-492 ◽

Cited By ~ 49

Author(s):

D.S. Krupashankar ◽

Sunil Dogra ◽

Mahendra Kura ◽

Abir Saraswat ◽

Leelavathy Budamakuntla ◽

...

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text